BioSpace News Archive

NeuroOne Medical Technologies Corporation announced that, effective April 4, 2022, the Compensation Committee of the Board of Directors approved an equity award under the NeuroOne Medical Technologies Corporation 2021 Inducement Plan, as a material inducement to an individual entering into employment with the Company.

Atara Biotherapeutics, Inc. today announces biopharmaceutical executive Charlene Banard will join as Chief Technical Officer.

Castle Biosciences to Present at the 21st Annual Needham Virtual Healthcare Conference.

Standard BioTools Inc. announced, as required by Nasdaq Stock Market Rules, the grant of equity inducement awards to its new executive officers Michael Egholm, the Company’s new President, Chief Executive Officer and a member of the Company’s Board of Directors, and Hanjoon Kim, the Company’s new Chief Operating Officer, and a new employee, Ardalan Arfaei, the Company’s new Senior Vice President, Corporate Development.

Cytonus Therapeutics Inc. (Cytonus), a biotechnology company developing therapeutic products for targeted delivery in vivo, announces that their CSO, Dr. Richard Klemke Ph.D., will present the preclinical progress made on Cytonus’ lead Cargocyte product candidates at the annual AACR meeting in New Orleans.

Battelle, the largest independent nonprofit applied science and technology organization in the world, and Spark Biomedical, Inc., a leading developer of wearable neurostimulation solutions, entered into a collaborative agreement to jointly run a pilot clinical study to advance remote detection and treatment of opioid use disorder (OUD).

Data presented at Microbiology Society Annual Conference, Belfast, 4-7 April 2022

Helix, a nationwide leader in population genomics, COVID-19 diagnostic testing and viral surveillance, has received FDA Emergency Use Authorization (EUA) for its SARS-CoV-2 Test and Helix COVID-19 Self-Collection Kit for use in a secure ‘Locker System’ – the first and only SARS-CoV-2 test authorized for use with a self-service test-retrieval system.

The National Eczema Association announces it has been awarded a competitive grant from Pfizer in the amount of $175K to support its novel research study titled “Atopic Dermatitis Flares – An Understanding and Definition from the Patient Perspective.” The grant period commenced in January 2022 with a timeline of 18 months.

Tevogen Bio announced the strategic expansion of its leadership team with two new executives to support the biotech’s rapid operational growth, manufacturing readiness, and the continued development and utilization of its next generation precision T cell platform technology.